Abstract-The effects of an adenosine analog, N6-phenyl-isopropyl-adenosine
Adenosine has been reported to regulate adenylate cyclase with stimulatory and/or inhibitory effects in many tissue systems (1) . The effects of nanomolar concentrations of adenosine are reported to be mediated through extra-cellular R-sites requiring in tegrity of the ribose ring, but modifications on the purine ring subdivided the receptor sites into stimulatory (A2 or Ra) and inhibitory ones (A, or Ri) (2, 3). The effects of higher than micromolar concentrations of adenosine appear to be mediated via intracellular P sites with an intact purine moiety, but modifi cation of the ribose moiety of the molecule caused it to be inhibitory towards the enzyme (1, 4) . Studies on adrenal tumor cells (5, 6) and bone cells (7) (+)-N6-phenylisopropyl-adenosine (PIA) and 3-methyl-1 -isobutylxanthine (IBMX) were from Boehringer-Mannheim, F.R.G. and Aldrich Chemical Co., Milwaukee, WI, respectively.
Preparation of hepatic membranes: Male rats of the Donryu strain (Nippon Rats Co., Ltd., Tokyo, Japan), weighing between 180 and 200 g, were used. After the liver had been perfused to remove blood, pieces of approx. 2.0 g were removed to the homogenization medium containing 154 mM NaCI, 20 mM sodium-Hepes (pH 7.5). Plasma membranes obtained from the procedure of Neville (15) up to step 1 1 were suspended in 10 volumes of 10 mM sodium-Hepes (pH 7.5), 1 mM mercapto-ethanol, centrifuged at 24,000 x g for 10 min at 4°C, washed three times, and dialyzed for 2 hr in the cold buffer containing 0.01% activated charcoal to remove endo genous adenosine associated with the mem branes. Membrane protein was determined by the method of Lowry et al. (16) .
Adenylate cyclase assays: Adenylate cyclase activity was estimated by incubation of the membranes in 40 mM Tris-HCI buffer (pH 7.4), containing 4 mM MgCl2, 5 mM theophylline, 2 mM ATP, 100 ag/ml pyruvate kinase, and 5 mM phosphoenolpyruvate for 10 min, as previously described (17) (18) (19) . Cyclic AMP formed during incubation was estimated by a competitive binding assay (20), using a protein purified from rabbit skeletal muscle through the DEAE-cellulose column step. 
Results
Hepatic adenylate cyclase activity from male adult rats was responsive to increasing concentrations of glucagon in the presence of 1 /iM GTP (Fig. 1) . As shown in Fig. 2 , stimulation by glucagon of adenylate cyclase activity was GTP-dependent.
Figs. 3 and 4 present the activation of adenylate cyclase by PIA with regard to GTP-dependency. The concentration of PIA required for half-maxi mal stimulation (ED50) was approximately 1.0 aaM (Fig. 3) . Concentrations of GTP required for half-maximal stimulation (ED50) were in the range of 0.1 ,oM (Fig. 4) . The stimulation by 10 nM glucagon of adenylate cyclase activity was attenuated by PIA in a dose-dependent manner (Fig. 5) . The con centration resulting in half-maximum inhibi tion (IC50) of PIA was in the range of nanomolar concentrations. This inhibition by PIA absolutely required the presence of 200 mM sodium chloride.
nucleotide.
GTP over 10 flM exclusively manifested a stimulation by glucagon (Fig.  6) . The inhibition by PIA of the glucagon stimulated enzyme was evident in the pre sence of 200 mM of sodium chloride and clearly antagonized with 0.1 mM IBMX (Fig.  7) . 
Discussion
Relatively large doses of adenosine (20 SaM) have been reported to inhibit adenylate cyclase activity in hepatic membranes (10, 11, (21) (22) (23) (24) , suggesting that the inhibition was mediated via intracellular P-sites re quiring an intact purine moiety, while modifi cations in the ribose portion had no effect on this action (1, 4 ). An increase in cellular cyclic AMP in the response to pharmacological con centrations (10 SaM) of adenosine and an A2 (or Ra) agonist such as 2-chloroadenosine has been reported in isolated rat hepatocytes (13, 14) . Moreover, Schultz et al. (12) have reported a stimulatory adenosine receptor (A2 or Ra) coupled to the adenylate cyclase system in rat liver plasma membranes. In the present experiment, PIA, an analogue of adenosine previously shown to be a specific R-site agonist at adenosine receptors (1, 25, 26) of the adenylate cyclase system was ob served to stimulate the enzyme at concen trations above the micromolar range, suggest ing the presence of the stimulatory adenosine receptor (A2 or Ra) in rat hepatic membranes.
On the other hand, the present experiment has shown the dose-dependent attenuation by PIA of the glucagon-stimulated adenylate cyclase activity. Londos and Preston (10) have reported that there was no inhibition of the glucagon-stimulated enzyme by adeno sine analogues related to a specific R site agonist. Attention, however, must be paid to their experimental conditions in which the adenylate cyclase activity has been assayed in the presence of Gpp(NH)p, a guanine nucleotide with exclusive stimulating action. In the adipocyte adenylate cyclase system, the adenosine receptor-mediated inhibition of the enzyme was observed to be absolutely dependent on GTP and amplified by sodium ions (27) (28) (29) . In the present experiment, the inhibition of the glucagon-stimulated ad enylate cyclase activity by PIA was apparent in the presence of a low concentration (1.0 ,eM) of GTP and sodium chloride. An inter action of the monovalent cation with the guanine nucleotide-binding regulatory com ponent, revealing hormone-induced inhibi tion or impairing hormone-induced stimula tion has been suggested (27-29). The in hibitory effect of PIA was antagonized by IBMX, which is selective for extracellular R site receptors. These results suggest a re ceptor-mediated inhibitory system (25, 30, 31) for adenosine on the hepatic membrane. A higher affinity for PIA inhibiting the gluca gon-stimulated activity in the nanomolar range can be compared with the far greater values (10 ooM) for adenosine (10, 11, 22 24) . The IC50 value for PIA (10 nM) is also compatible with those (10 to 100 nM) in the brain (32, 33), fat cells (3, 34), heart (35) and adrenocortical cells (9). The inhibition by PIA fortified with sodium chloride was ob served in the presence GTP in the micromolar range, indicating the effect of the guanine nucleotide inhibitory system (NO linked to the enzyme.
The inhibitory effects of the glucagon stimulated enzyme activity by PIA disappeared and reversed into a stimulatory phase with in creasing concentrations of GTP (more than 10 flM), suggesting the presence of a stimula tory (Ns) and an inhibitory (NO guanine nucleotide system of the enzyme in the ac tion of PIA. The concentrations of the nucleo side required to produce a receptor-mediated inhibitory effect on the glucagon-stimulated adenylate cyclase were less than the micro molar range and of physiological significance, considering the fact that the circulating plasma levels of adenosine have been re ported to be less than 2 ,oM (36).
The present experiments suggest that adenosine in the micromolar range has dual effects on the hepatic adenylate cyclase sys tem through the stimulatory receptor (Ra or A2) and the inhibitory receptor (Ri or A1), depending on the cellular concentrations of GTP and/or sodium chloride.
